Circulating leptin levels and risk of colorectal cancer and adenoma: A case-control study and meta-analysis

Cancer Causes and Control

Volumn 24, Issue 12, 2013, Pages 2129-2141

  Gialamas, Spyros P ^a   Sergentanis, Theodoros N ^a   Antonopoulos, Constantine N ^a   Dessypris, Nick ^a   Chrousos, George P ^a   Petridou, Eleni Th ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Circulating leptin; Colorectal adenoma; Colorectal cancer; Meta analysis; Obesity

Indexed keywords

LEPTIN;

ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COLORECTAL ADENOMA; COLORECTAL CANCER; COMORBIDITY; HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ADENOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; HUMANS; LEPTIN; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84889035200     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0290-1     Document Type: Article

References (50)

1. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569-578. doi: 10.1016/s0140-6736(08) 60269-x
2. Donohoe CL, Pidgeon GP, Lysaght J, Reynolds JV (2010) Obesity and gastrointestinal cancer. Br J Surg 97(5):628-642. doi: 10.1002/bjs.7079
3. Okabayashi K, Ashrafian H, Hasegawa H, Yoo JH, Patel VM, Harling L, Rowland SP, Ali M, Kitagawa Y, Darzi A, Athanasiou T (2012) Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 107(8): 1175-1185; quiz 1186. doi: 10.1038/ajg.2012.180
4. Pendyala S, Neff LM, Suarez-Farinas M, Holt PR (2011) Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. Am J Clin Nutr 93(2):234-242. doi: 10.3945/ajcn.110.002683
5. Howard JM, Pidgeon GP, Reynolds JV (2010) Leptin and gastro-intestinal malignancies. Obes Rev: Off J Int Assoc Study Obes 11(12):863-874. doi: 10.1111/j.1467-789X.2010.00718.x
6. Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, Fujita S, Kato K, Hamaguchi T, Shimada Y (2010) Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 101(5):1286-1291
7. Uchiyama T, Takahashi H, Endo H, Sugiyama M, Sakai E, Hosono K, Nagashima Y, Inayama Y, Wada K, Hippo Y, Nakajima A (2011) Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression. Int J Oncol 39(4):935-940
8. Tamakoshi K, Toyoshima H, Wakai K, Kojima M, Suzuki K, Watanabe Y, Hayakawa N, Yatsuya H, Kondo T, Tokudome S, Hashimoto S, Suzuki S, Kawado M, Ozasa K, Ito Y, Tamakoshi A (2005) Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncology 68(4-6):454-461
9. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E (2004) Obesity and colon cancer: does leptin provide a link? Int J Cancer J Int Cancer 109(1):149-152
10. Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, McTiernan A, Potter JD (2007) Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev: Publ Am Assoc Cancer Res, Cosponsored Am Soc Prev Oncol 16(12):2697-2703
11. Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 1229:45-52. doi: 10.1111/j.1749-6632.2011.06096.x
12. Svobodova S, Topolcan O, Holubec L Jr, Levy M, Pecen L, Svacina S (2011) Parameters of biological activity in colorectal cancer. Anticancer Res 31(1):373-378
13. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E (2009) Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis 24(3):275-281
14. Arpaci F, Yilmaz MI, Ozet A, Ayta H, Ozturk B, Komurcu S, Ozata M (2002) Low serum leptin level in colon cancer patients without significant weight loss. Tumori 88(2):147-149
15. Otake S, Takeda H, Fujishima S, Fukui T, Orii T, Sato T, Sasaki Y, Nishise S, Kawata S (2010) Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol: WJG 16(10):1252-1257
16. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, J Am Med Assoc 283(15):2008-2012
17. Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13. doi: 10.1186/1471-2288-5-13
18. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer J Int Cancer 121(4):856-862. doi: 10.1002/ijc.22717
19. Siristatidis C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, Psaltopoulou T, Skalkidou A, Petridou ET (2013) Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer-a systematic review and meta-analysis. Hum Reprod Update 19(2):105-123. doi: 10.1093/humupd/dms051
20. Higgins JPT GS Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from www.cochrane-handbook.org
21. Al Khaldi RM, Al Mulla F, Al Awadhi S, Kapila K, Mojiminiyi OA (2011) Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer. Dis Markers 30(4):197-212
22. Aleksandrova K, Boeing H, Jenab M, Bueno-de-Mesquita HB, Jansen E, Van Duijnhoven FJB, Rinaldi S, Fedirko V, Romieu I, Riboli E, Gunter MJ, Westphal S, Overvad K, Tjnoneland A, Halkjrae J, Racine A, Boutron-Ruault MC, Clavel-Chapelon F, Kaaks R, Lukanova A, Trichopoulou A, Lagiou P, Trichopoulos D, Mattiello A, Pala V, Palli D, Tumino R, Vineis P, Buckland G, Sanchez MJ, Amiano P, Huerta JM, Barricarte A, Menendez V, Peeters PH, Soderberg S, Palmqvist R, Allen NE, Crowe FL, Khaw KT, Wareham N, Pischon T (2012) Leptin and soluble leptin receptor in risk of colorectal cancer in the European prospective investigation into cancer and nutrition cohort. Cancer Res 72(20):5328-5337
23. Bolukbas FF, Kilic H, Bolukbas C, Gumus M, Horoz M, Turhal NMS, Kavakli B (2004) Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC cancer 4:29
24. Catalan V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, Silva C, Rotellar F, Hernandez-Lizoain JL, Baixauli J, Valenti V, Pardo F, Salvador J, Fruhbeck G (2011) Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. J Nutr Biochem 22(7):634-641
25. Cong JC, Dai XW, Shen MY, Wang JJ, Chen CS, Zhang H, Qiao L (2009) Expression of obesity hormone leptin in human colorectal cancer. Chin J Cancer Res 21(2):142-146
26. Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D'Alessandro R, Del Monte G, Formica V, Laudisi A, Portarena I, Palmirotta R, Ferroni P (2009) Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res 29(8):3321-3327
27. Ho GYF, Wang T, Gunter MJ, Strickler HD, Cushman M, Kaplan RC, Wassertheil-Smoller S, Xue X, Rajpathak SN, Chlebowski RT, Vitolins MZ, Scherer PE, Rohan TE (2012) Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res 72(12):3029-3037
28. Huang Q, Fan YZ, Ge BJ, Zhu Q, Tu ZY (2007) Circulating ghrelin in patients with gastric or colorectal cancer. Dig Dis Sci 52(3):803-809
29. Jiang B, Liu DB, Zhang X, Du LL, Han CZ (2009) Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer. Zhonghua wei chang wai ke za zhi = Chin J Gastrointest Surg 12(3):264-268
30. Kang HR, Jiang J, Xiao WH (2010) Serum leptin levels in patients with colon cancer and its significance. J Pract Oncol 25(2):177-179
31. Kemik O, Sumer A, Kemik AS, Hasirci I, Purisa S, Dulger AC, Demiriz B, Tuzun S (2010) The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol 8:85
32. Kosova F, Coskun T, Kaya Y, Kara E, Ari Z (2011) Adipocytokine levels of colon cancer patients before and after treatment. Turk J Biochem 36S(2):216
33. Salageanu A, Tucureanu C, Lerescu L, Caras I, Pitica R, Gangura G, Costea R, Neagu S (2010) Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life 3(4):416-420
34. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, Kaaks R, Stattin P (2008) Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes 2005 32(2):304-314
35. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, Benedetto C, Mussa A (2000) Leptin expression in colorectal and breast cancer patients. Int J Mol Med 5(4):421-426
36. Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, Mejean C, Latino-Martel P, Hercberg S, Galan P, Czernichow S (2012) Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk. World J Gastroenterol: WJG 18(22):2805-2812
37. Uchiyama T, Takahashi H, Sugiyama M, Sakai E, Endo H, Hosono K, Yoneda K, Yoneda M, Inamori M, Nagashima Y, Inayama Y, Wada K, Nakajima A (2011) Leptin receptor is involved in STAT3 activation in human colorectal adenoma. Cancer Sci 102(2):367-372
38. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S (2010) Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res 70(13):5430-5437
39. Gialamas SP, et al Unpublished
40. de Heer J (2012) Obesity, metabolic syndrome and cancer genesis - Epidemiology and possible causes. Diabetologe: 1-6
41. Kim HJ, Yun J, Kim KH, Kim SH, Lee SC, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Park HS, Hong DS (2012) Pathophysiological role of hormones and cytokines in cancer cachexia. J Korean Med Sci 27(2):128-134
42. Richards CH, Roxburgh CS, MacMillan MT, Isswiasi S, Robertson EG, Guthrie GK, Horgan PG, McMillan DC (2012) The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS One 7(8):e41883. doi: 10.1371/journal.pone.0041883
43. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C (2000) Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 14(14):2329-2338. doi: 10.1096/fj.00-0162
44. Wang D, Chen J, Chen H, Duan Z, Xu Q, Wei M, Wang L, Zhong M (2012) Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3 K/Akt/mTOR signalling pathway. J Biosci 37(1):91-101
45. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR (1998) Biological action of leptin as an angiogenic factor. Science (New York, NY) 281(5383):1683-1686
46. Drew JE (2012) Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin. Proc Nutr Soc 71(1):175-180
47. Moses AG, Dowidar N, Holloway B, Waddell I, Fearon KC, Ross JA (2001) Leptin and its relation to weight loss, ob gene expression and the acute-phase response in surgical patients. Br J Surg 88(4):588-593. doi: 10.1046/j.1365-2168.2001.01743.x
48. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S (2007) Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 60(8):902-906
49. Uddin S, Bavi PP, Hussain AR, Alsbeih G, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Ahmed M, Al-Kuraya KS (2009) Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis 30(11):1832-1840
50. Aloulou N, Bastuji-Garin S, Le Gouvello S, Abolhassani M, Chaumette MT, Charachon A, Leroy K, Sobhani I (2008) Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res 68(22):9413-9422